Standards for authorizing first-time trials of drugs in humans are lax, and should be strengthened in several ways, McGill University researchers argue in a paper published today in Nature.
The end of September saw the formation of a new team of rivals: the Partnership on AI, whose motto is "to benefit people and society". The partnership includes tech giants Amazon, Google and its subsidiary Deepmind, Facebook, IBM and Microsoft.
Guidance addresses key scientific, ethical, social, and policy challenges raised by new technologies and emerging areas of stem cell discovery and application
Prescriptions for dangerous alternatives to OxyContin are soaring, showing that a crackdown on the popular painkiller has failed to curb Canada’s opioid crisis.
Policy experts advocate mutual recognition for reviews of data-intensive international research
Genomic research holds great potential to advance human health and medicine. But for the millions of data points now being collected through large-scale sequencing efforts to be truly valuable, they must be analyzed in aggregate and shared across institutions and jurisdictions. This raises many challenges, including navigation of complex ethics-approval processes at multiple sites and in multiple jurisdictions.